Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs SexyMD

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and SexyMD head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 131 · Grade C

SexyMD

Visit SexyMD Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 72 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make SexyMD a bad call — it's best for readers comparing shorter supplies with longer commitments who will confirm the total charge and renewal cadence before submitting an order. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
48
Supply Reliability
95
75
Transparency
90
88
Access Breadth
93
84
Clinical Oversight
92
73
Track Record
88
69
CoreAge RxBrief Score 94 · 72SexyMD

Price, coverage & the tracker

CoreAge RxSexyMD
Brief Score94/100 (A)72/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$149 per four-week supply

Flexible compounded option. The $99 equivalent belongs to a 48-week plan; confirm the complete longer-plan charge.

Full price details

$149 for the listed 4-week compounded semaglutide flexible supply; $99/month equivalent requires the listed 48-week plan; full long-plan charges need confirmation

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$199 per four-week supply

Flexible compounded option. The $129 equivalent belongs to a 48-week plan; confirm the complete longer-plan charge.

Full price details

$199 for the listed 4-week compounded tirzepatide flexible supply; $129/month equivalent requires the listed 48-week plan; full long-plan charges need confirmation

CoverageUS only; restrictions by state, confirmed at intakeAdvertises all 50 states with medication, provider-licensure and pharmacy exceptions
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

SexyMD: Flexible four-week supplies list $149 semaglutide and $199 tirzepatide. The $99/$129 figures belong to the 48-week plan and are not flexible monthly prices.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.